There is a 340B angle in the fight in the U.S. House over who should be third in the Republican leadership ranks.
The GOP caucus is expected to vote tomorrow to remove Rep. Liz Cheney (R-Wyo.) as House Republican Conference
…
Month: May 2021
Drug manufacturer Eli Lilly yesterday asked a federal district judge in Indianapolis to schedule oral argument as soon as mid-June in its lawsuit challenging both a federal legal advisory opinion about 340B contract pharmacy and the 340B program’s new administrative
…
SPONSORED CONTENT
By: Diana Sierra, MPH, VP, Contract Pharmacy Partnership & RVS Operations, Sentry Data Systems
For years, covered entities generated savings from the 340B program largely by contracting with retail pharmacies. Brick-and-mortar storefronts in their local communities, many of them trailblazing independent pharmacies, provided the most benefit for covered entities in the early years of the program.
In the past five or six years, however, there’s been a significant uptick in hospitals contracting with specialty pharmacies. That’s coincided with a rapid growth in the number of high-priced specialty drugs, which comprised about 36% of the overall prescription-drug market in 2019, up from 29% in 2015, according to Drug Channels Institute, making them the fastest-growing and largest category of medications.
Provided you have a solid grasp of sometimes complex specialty drug dispensing fee models, contracting with specialty pharmacies is a smart and relatively low-risk way to maximize your 340B benefits. But specialty drugs and the relationship between covered entities and specialty pharmacies
…
Arkansas’s and Indiana’s governors have signed bills in recent days to prevent pharmacy benefit managers (PBMs) from discriminating against 340B covered entities, and a similar bill is awaiting the Tennessee governor’s signature.
Arkansas Gov. Asa Hutchinson (R) signed his state’s
…
The plain language of the 340B statute “explicitly requires drug manufacturers to offer 340B discounts to 340B covered entities regardless of whether the drugs are dispensed by the entity or by an outside pharmacy with which the entity has a
…
Katheryne Richardson, a long time Apexus vice president who was instrumental in launching its 340B University educational program and Apexus Answers call center, is moving to Bristol-Myers Squibb (BMS) to become the drug manufacturer’s 340B program strategist.
Her move to
…
Policymakers should make better use of the 340B program to help eliminate “pharmacy deserts” in Black and Hispanic/Latino urban neighborhoods, new research published in Health Affairs recommends.
The study was conducted by researchers at four universities and supported by the
…
A powerful U.S. House health subcommittee has invited U.S. health secretary Xavier Becerra to brief it next week about his department’s discretionary budget request for the coming fiscal year, and to discuss how they might collaborate on lowering drug prices
…SPONSORED CONTENT
The devastating double-whammy of Medicare Part B payment cuts and COVID-19 has again highlighted the 340B program’s significance to hospital finance. Once relegated to the hospital’s basement pharmacy, the 340B program is increasingly a topic of boardroom and C-suite discussions.
In the latest episode of Omnicell’s The Future of Pharmacy podcast, learn how health systems can leverage a vibrant, pharmacy-finance partnership to drive successful 340B programs, and allow pharmacy staff more time to focus on patient care. Find out why 340B program management has evolved, the program challenges that health systems still face, and the data and operational complexities that necessitate a cross-functional approach.
Host:
Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell
Guest experts:
- Eric Iorfido, PharmD, 340B Program Manager, Penn Highlands DuBois
- Charles Hirner, RPh, Senior Director, Omnicell 340B Operations
…